Ibopamine as a Valuable Adjunct and Substitute for Dopamine in Bridging Therapy before Heart Transplantation

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Ibopamine is an active dopamine analogue leading to improved renal perfusion and afterload reduction in heart failure. This report describes casuistic experiences in patients with severe heart failure awaiting heart transplantation. All patients could be stabilized, intravenous catecholamines be discontinued, and diuretics be reduced. Six of seven patients could be successfully transplanted. No major side effects were noted. Thus ibopamine can be a suitable adjunct for patients with endstage heart failure.

Related collections

Author and article information

Journal

Journal ID (publisher-id): CRD

Journal ID (nlm-ta): Cardiology

Journal ID (doi): 10.1159/issn.0008-6312

Title: Cardiology

Publisher: S. Karger AG

ISSN (Print): 0008-6312

ISSN (Electronic): 1421-9751

Publication date Subscription-year: 1992

Publication date (Print): 1992

Publication date (Electronic): 14 November 2008

Volume: 81

Issue: 2-3

Pages: 121-124

Affiliations

Krankenhaus München-Schwabing, Akademisches Lehrkrankenhaus der, Ludwig-Maximilians-Universität München, Elisabeth-Krankenhaus, Akademisches, Lehrkrankenhaus der Universität (Gesamthochschule) Essen, Zambon GmbH, München, Klinik Schindlbeck, Herrsching, BRD; Allgemeines Krankenhaus der, Stadt Wien, Kardiologische, Universitätsklinik, Wien, Österreich

Article

Publisher ID: 175786 Other ID: Cardiology 1992;81:121–124

DOI: 10.1159/000175786

PubMed ID: 1286470

SO-VID: 4d0a4deb-e8f9-4e76-93f5-3a87f1cd6d89

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Date received : 08 June 1992

Date accepted : 06 July 1992

Page count

Pages: 4

Call for Papers: Novel Methods in Vascular and Lymphatic Physiology

Submit here by June 30, 2025

Ibopamine as a Valuable Adjunct and Substitute for Dopamine in Bridging Therapy before Heart Transplantation

Read this article at

Abstract

Related collections

Karger: Cardiovascular System

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 494